Skip to content

Choukri Ben Mamoun

YSM10018_0578_C_Ben Mamoun

EliV5 Therapeutics

2019

Affiliations

Yale University

Technologies

Therapeutic

Indication

Basic Research

Drug Discovery

Infectious Disease

Executive Summary

View/Download

EliV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence.

Newsletter Signup

Corporate Supporters

ABCT is a Program of

An intiative of